HCV Genetic Elements Determining the Early Response to Peginterferon and Ribavirin Therapy

Publisher： Karger

E-ISSN： 1423-0100|53|1|66-69

ISSN： 0300-5526

Source： Intervirology, Vol.53, Iss.1, 2010-01, pp. : 66-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon‐naïve patients with HIV/HCV genotype 2/3 co‐infection in Italy

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 1, 2015-01 ,pp. : 120-129

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association between HCV amino acid substitutions and outcome of peginterferon and ribavirin combination therapy in HCV genotype 1b and high viral load

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 6, 2010-06 ,pp. : 1072-1078

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characteristics and Outcomes of HCV Genotype-1-Infected Patients Treated with Peginterferon and Ribavirin Combination Therapy with Discordant HCV Responses 4 and 12 Weeks after Starting Therapy

By  

Intervirology, Vol. 57, Iss. 5, 2014-06 ,pp. : 289-296

Karger

Access to resources Recommend Favorite

O‐27: Early HCV RNA kinetics predict relapse to sofosbuvir/ribavirin dual therapy

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 16-16

John Wiley & Sons Inc

Access to resources Recommend Favorite

Amino Acid Substitution in HCV Core Region and Genetic Variation near the IL28B Gene Affect Viral Dynamics during Telaprevir, Peginterferon and Ribavirin Treatment

By  

Intervirology, Vol. 55, Iss. 6, 2012-06 ,pp. : 417-425

Karger

Access to resources Recommend Favorite